Hematology and Oncology Research deals with the study of blood disorders and cancer, respectively. These two fields are closely related as patients with cancer usually require blood tests and other hematology evaluations throughout their treatment. Cancer is a complex disease that arises when cells in the body sta…
Hematology and Oncology Research deals with the study of blood disorders and cancer, respectively. These two fields are closely related as patients with cancer usually require blood tests and other hematology evaluations throughout their treatment. Cancer is a complex disease that arises when cells in the body start growing abnormally and uncontrollably. Hematology and oncology researchers have been at the forefront of developing new and innovative treatment options to combat these malignant cells. Treatment options include surgery, radiation therapy, chemotherapy, immunotherapy, and targeted therapy. Surgery is used to physically remove the cancerous growth, while radiation therapy uses high-energy radiation to kill the cancer cells. Chemotherapy involves the use of drugs to kill or slow the growth of cancer cells. Immunotherapy uses the body's immune system to fight the cancer cells, while targeted therapy targets specific genes or proteins to halt the growth and spread of cancer cells. Hematology research focuses on the study of blood disorders such as sickle cell anemia, hemophilia, and blood cancers like leukemia and lymphoma. Researchers in this field are working on developing treatments that can replace unhealthy blood cells with healthy ones, like bone marrow transplant or gene therapy. They are also exploring new therapies that target specific proteins or markers on abnormal blood cells. In summary, Hematology and Oncology Research are critical fields that are continuously exploring new and innovative ways to treat cancer and blood disorders. Researchers in these fields are working tirelessly to find effective treatments that can save lives and improve patients' quality of life. By optimizing the use of therapies and developing new treatment options, we can continue to improve the outlook for patients with cancer and other blood disorders.
3 peer-reviewed articles, ranked by relevance. Each links to its DOI.
The 3 articles above have been cited 12 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
A sample of recent works citing this journal's research on Malignancy Treatment, linking to each citing work.